Compare BRNS & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRNS | PDSB |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.9M | 46.0M |
| IPO Year | 2021 | N/A |
| Metric | BRNS | PDSB |
|---|---|---|
| Price | $0.69 | $0.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | ★ $9.00 |
| AVG Volume (30 Days) | 101.8K | ★ 641.8K |
| Earning Date | 11-07-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1766.46 | N/A |
| 52 Week Low | $0.64 | $0.70 |
| 52 Week High | $2.92 | $2.20 |
| Indicator | BRNS | PDSB |
|---|---|---|
| Relative Strength Index (RSI) | 33.40 | 57.25 |
| Support Level | $0.66 | $0.83 |
| Resistance Level | $0.78 | $1.13 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 7.88 | 63.49 |
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.